GTS Securities’s Pacific Biosciences PACB Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | – | Sell |
-12,509
| Closed | -$14.8K | – | 1503 |
|
|
2025
Q1 | $14.8K | Buy |
+12,509
| New | +$14.8K | ﹤0.01% | 1202 |
|
|
2024
Q4 | – | Sell |
-20,188
| Closed | -$34.3K | – | 1892 |
|
|
2024
Q3 | $34.3K | Sell |
20,188
-13,801
| -41% | -$23.5K | ﹤0.01% | 1625 |
|
|
2024
Q2 | $46.6K | Sell |
33,989
-3,456
| -9% | -$4.74K | ﹤0.01% | 1465 |
|
|
2024
Q1 | $140K | Sell |
37,445
-279,090
| -88% | -$1.05M | ﹤0.01% | 1242 |
|
|
2023
Q4 | $3.11M | Buy |
316,535
+95,943
| +43% | +$941K | 0.01% | 280 |
|
|
2023
Q3 | $1.84M | Buy |
220,592
+12,793
| +6% | +$107K | ﹤0.01% | 351 |
|
|
2023
Q2 | $2.76M | Buy |
+207,799
| New | +$2.76M | 0.09% | 213 |
|